| Stock Name | 健康之路 |
|---|---|
| Stock Code | 02587 |
| Company Full Name | 健康之路 |
| Industry | 軟件服務 |
| Principal Activities | 公司是中國經營數字健康醫療服務平臺。 |
| Listing Date | 2024-12-30 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國福建省福州市鼓樓區軟件大道89號福州軟件園F區3號樓22樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.jkzlkj.cn/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.80 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2024-12-18 to 2024-12-23 |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 51.2% |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 25,740,000 |
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 4,400 |
| 2 lots | 1,000 | HK$ 8,800 |
| 3 lots | 1,500 | HK$ 13,200 |
| 4 lots | 2,000 | HK$ 17,600 |
| 5 lots | 2,500 | HK$ 22,000 |
| 6 lots | 3,000 | HK$ 26,400 |
| 7 lots | 3,500 | HK$ 30,800 |
| 8 lots | 4,000 | HK$ 35,200 |
| 9 lots | 4,500 | HK$ 39,600 |
| 10 lots | 5,000 | HK$ 44,000 |
| 12 lots | 6,000 | HK$ 52,800 |
| 14 lots | 7,000 | HK$ 61,600 |
| 16 lots | 8,000 | HK$ 70,400 |
| 18 lots | 9,000 | HK$ 79,200 |
| 20 lots | 10,000 | HK$ 88,000 |
| 30 lots | 15,000 | HK$ 132,000 |
| 40 lots | 20,000 | HK$ 176,000 |
| 50 lots | 25,000 | HK$ 220,000 |
| 60 lots | 30,000 | HK$ 264,000 |
| 70 lots | 35,000 | HK$ 308,000 |
| 80 lots | 40,000 | HK$ 352,000 |
| 90 lots | 45,000 | HK$ 396,000 |
| 100 lots | 50,000 | HK$ 440,000 |
| 120 lots | 60,000 | HK$ 528,000 |
| 140 lots | 70,000 | HK$ 616,000 |
| 160 lots | 80,000 | HK$ 704,000 |
| 180 lots | 90,000 | HK$ 792,000 |
| 200 lots | 100,000 | HK$ 880,000 |
| 300 lots | 150,000 | HK$ 1,320,000 |
| 400 lots | 200,000 | HK$ 1,760,000 |
| 500 lots | 250,000 | HK$ 2,200,000 |
| 600 lots | 300,000 | HK$ 2,640,000 |
| 700 lots | 350,000 | HK$ 3,080,000 |
| 800 lots | 400,000 | HK$ 3,520,000 |
| 900 lots | 450,000 | HK$ 3,960,000 |
| 1,000 lots | 500,000 | HK$ 4,400,000 |
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,200 lots | 600,000 | HK$ 5,280,000 |
| 1,400 lots | 700,000 | HK$ 6,160,000 |
| 1,600 lots | 800,000 | HK$ 7,040,000 |
| 2,000 lots | 1,000,000 | HK$ 8,800,000 |
| 2,200 lots | 1,100,000 | HK$ 9,680,000 |
| 2,500 lots | 1,250,000 | HK$ 11,000,000 |
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 10.66 |
|---|---|
| First Day Open | HK$ 9.95 |
| First Day Change | 36.67% |
| First Day Volume | 3281100.0 |
| First Day Turnover | 32586100.0 |
| Use of Proceeds | 1、約33.5%或約40.6百萬港元擬于未來三年用于業務發展，特別是健康醫療服務； 2、約27.0%或約32.7百萬港元擬用于未來三年的業務發展，特別是企業服務及數字營銷服務； 3、約21.0%或約25.4百萬港元擬用作戰略投資或收購； 4、約14.5%或約17.5百萬港元將用作研發； 5、約4.0%或約4.8百萬港元預期將用作營運資金及一般企業用途。 |
|---|
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 横琴粤澳深度合作区产业投资基金(有限合伙) | 99,894,600 HKD | — | 51.23% | — | 6 months | 2025-06-30 |
| Chairman | 張萬能 |
|---|---|
| Company Secretary | 陳宙峰,談俊緯 |
| Major Shareholders & Holdings | 豐基有限公司(33.71%),百度(香港)有限公司(12.10%),佳滿集團投資有限公司(10.43%),美逸有限公司(9.23%) |
|---|
Market Sentiment
健康之路 IPO saw a retail oversubscription of 34.42 times, indicating moderate market enthusiasm. The overall hit rate was 65.96%, meaning about two-thirds of valid applicants received allocations, which is relatively high. The final offer price of HK$7.8 was fixed, with no pricing range to gauge demand intensity. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Tier Analysis
A notable tier anomaly exists: the A-tail (applied 500,000 lots) expected only 0.53 lots on average, while the B-head (600,000 lots) expected 1 lot, showing a disproportionate jump in allocation efficiency at the B threshold. This inefficiency means A-tail applicants faced a high chance of receiving zero lots despite a substantial subscription. Broker fee efficiency would vary significantly across tiers, with B-head offering better per-lot allocation. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Demographics
Demographic breakdown data is unavailable for this IPO, with total holders, mainland China participation, and Hong Kong participation all reported as zero. Without demographic data, it is impossible to assess regional or gender participation patterns. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
